Regeneron Weight-Loss Drug

Lilly's Next-Gen Drug Tops Zepbound on Weight Loss

Pfizer turns to China for trial weight loss drug. Congress is worried about Chinese biotechs.

Big American drugmakers are hunting for novel weight loss drugs in the labs of China’s biotech industry, while U.S. authorities try to undercut the growing Chinese biotech sector.

· 2d · on MSN

Eli Lilly Reports Dramatic Weight Loss in Next-Gen Obesity-Drug Trial

· 2d

Lilly's Next-Gen Drug Tops Zepbound on Weight Loss in Late-Stage Osteoarthritis Trial

New weight loss drug dubbed 'triple G' shows promise: What to know about retatrutide

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.

10d

Companies Cut Prices For Blockbuster Weight-Loss Drugs

In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...

Major Weight Loss and Knee-Pain Relief Seen With New Eli Lilly Drug

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

3don MSN

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial

A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...

12d

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?

Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results